CATXbenzinga

Perspective Therapeutics FY 2024 GAAP EPS $(1.23) Misses $(0.87) Estimate, Sales $1.454M Beat $1.348M Estimate

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 26, 2025 by benzinga